NanoString Technologies Inc (NSTG):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:NanoString Technologies Inc (NSTG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8018
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
NanoString Technologies Inc (NanoString) is a developer of life science tools for translational research and molecular diagnostics. The company’s products include sprint profiler, Dx analysis system with flex, nCounter MAX analysis system, protein assays, solid tumor assays, gene fusion panels, RNA panels, DNA assays, immunology panel, gene expression codesets, pancancer immune profiling and pathways, among others. Its nCounter MAX analysis system provides cost-effective method to profile various miRNA, miRGE or DNA molecules simultaneously employing a novel digital molecular barcoding technology. The company sells its products through direct sales force and distributors in Austria, Poland, Czech Republic, Slovakia, Hungary, Croatia, Slovenia, Bosnia Herzegovina, Serbia, Romania, Albania, Macedonia and Bulgaria, among others. NanoString is headquartered in Seattle, Washington, the US.

NanoString Technologies Inc (NSTG) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
NanoString Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
NanoString Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 10
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
NanoString Technologies Raises US$0.2 Million In Venture Financing 12
NanoString Technologies Raises US$15 Million In Series E Financing 13
NanoString Technologies To Raise US$0.65 Million In Venture Financing 15
Partnerships 16
NanoString Technologies Enters into Agreement with OHSU Knight Cancer Institute 16
NanoString Enters into Research Agreement with CITN for Novel Cancer Immunotherapies 17
NanoString Enters into Co-Development Agreement with Celgene 18
NanoString Technologies And BD Biosciences Enter Into Agreement To Develop Single Cell Isolation And Analysis Workflow 19
Licensing Agreements 20
NanoString Technologies Enters Into Option For Licensing Agreement With Massachusetts General Hospital 20
Equity Offering 21
NanoString Technologies Completes Underwriters Exercise of Over-Allotment Option of Public offering of Shares of Shares for USD57.5 Million 21
NanoString Technologies Plans to Raise up to USD40 Million in Private Placement of Shares 23
NanoString Technologies Completes Public Offering Of Shares For US$55 Million 24
NanoString Technologies Completes IPO Of Shares For US$54 Million 26
NanoString Technologies Inc – Key Competitors 28
NanoString Technologies Inc – Key Employees 29
NanoString Technologies Inc – Locations And Subsidiaries 30
Head Office 30
Recent Developments 31
Financial Announcements 31
Aug 07, 2018: NanoString Technologies Releases Operating Results for Second Quarter of 2018 31
Jul 16, 2018: NanoString Technologies Provides Preliminary Revenue Results for Second Quarter 2018 33
May 08, 2018: NanoString Technologies Releases Operating Results for First Quarter of 2018 34
Jan 08, 2018: NanoString Technologies Provides Preliminary Operational and Financial Results for Fourth Quarter and Fiscal Year 2017 36
Nov 02, 2017: NanoString Technologies Releases Operating Results for Third Quarter of 2017 37
Oct 11, 2017: NanoString Announces Preliminary Revenue for Third Quarter of Fiscal Year 2017 38
Aug 08, 2017: NanoString Technologies Releases Operating Results for Second Quarter of 2017 39
May 04, 2017: NanoString Technologies Releases Operating Results for First Quarter of 2017 40
Mar 01, 2017: NanoString Technologies Releases Fourth Quarter and Full Year 2016 Operating Results and Provides 2017 Outlook 41
Jan 10, 2017: NanoString Technologies Provides Preliminary Operational and Financial Results for 2016 42
Corporate Communications 43
May 10, 2017: NanoString Appoints Elisha W. Finney to Board of Directors 43
Product News 44
Apr 03, 2017: Digital Spatial Profiling Technology Enables Quantitative Protein Profiling in FFPE Tissue Providing Detailed Molecular Characterization of Immune Response to Tumors 44
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
NanoString Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
NanoString Technologies Inc, Deals By Therapy Area, 2012 to YTD 2018 9
NanoString Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 10
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
NanoString Technologies Raises US$0.2 Million In Venture Financing 12
NanoString Technologies Raises US$15 Million In Series E Financing 13
NanoString Technologies To Raise US$0.65 Million In Venture Financing 15
NanoString Technologies Enters into Agreement with OHSU Knight Cancer Institute 16
NanoString Enters into Research Agreement with CITN for Novel Cancer Immunotherapies 17
NanoString Enters into Co-Development Agreement with Celgene 18
NanoString Technologies And BD Biosciences Enter Into Agreement To Develop Single Cell Isolation And Analysis Workflow 19
NanoString Technologies Enters Into Option For Licensing Agreement With Massachusetts General Hospital 20
NanoString Technologies Completes Underwriters Exercise of Over-Allotment Option of Public offering of Shares of Shares for USD57.5 Million 21
NanoString Technologies Plans to Raise up to USD40 Million in Private Placement of Shares 23
NanoString Technologies Completes Public Offering Of Shares For US$55 Million 24
NanoString Technologies Completes IPO Of Shares For US$54 Million 26
NanoString Technologies Inc, Key Competitors 28
NanoString Technologies Inc, Key Employees 29

List of Figures
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
NanoString Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[NanoString Technologies Inc (NSTG):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Srei Infrastructure Finance Ltd
    Srei Infrastructure Finance Ltd - Strategy, SWOT and Corporate Finance Report Summary Srei Infrastructure Finance Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Dynatronics Corp (DYNT):医療機器:M&Aディール及び事業提携情報
    Summary Dynatronics Corp (Dynatronics) is a medical device company that offers rehab technology and equipment solutions. The company offers modalities, hot and cold therapy, clinical accessories, body positioning, sports medicine, orthopedics, hand therapy, strength equipment, treatment tables and r …
  • Arca Continental SAB de CV:企業の戦略・SWOT・財務情報
    Arca Continental SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Arca Continental SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • 3W Power S.A. (3W9K):電力:M&Aディール及び事業提携情報
    Summary 3W Power S.A. (3W Power) is a provider of energy equipment and services. It offers power supply systems and solutions. The company provides the most comprehensive product and service portfolios in uninterruptible power supply and power management fields. 3W Power offers a range of services s …
  • InspireMD Inc (NSPR):医療機器:M&Aディール及び事業提携情報
    Summary InspireMD Inc (InspireMD) is a medical device company that develops and commercializes embolic prevention systems and neurovascular devices. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for us …
  • Steris Plc (STE):製薬・医療:M&Aディール及び事業提携情報
    Summary Steris Plc (Steris), formerly Steris Ltd is a medical equipment company that provides infection prevention and other procedural products. The company offers products such as OR integration systems, sterilizers, surgical tables and lights, perioperative solutions, endoscopy accessories and ba …
  • Bunge Ltd (BG):企業の財務・戦略的SWOT分析
    Bunge Ltd (BG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • WAVE Life Sciences Ltd (WVE):企業の財務・戦略的SWOT分析
    Summary Wave Life Sciences Ltd (Wave Life Sciences) formerly WAVE Life Sciences Pte Ltd, discovers, develops and commercializes medicines for genetic diseases. The company's pipeline comprises an mRNA transcript candidates: WVE-120101 and WVE-120102 for Huntington's disease; ATXN3 gene candidate for …
  • MetaStat Inc (MTST):製薬・医療:M&Aディール及び事業提携情報
    Summary MetaStat Inc (MetaStat) is a biotechnology company that discovers and develops personalized diagnostic and therapeutic treatment solutions for cancer patients. The company develops therapeutic product candidates based on novel approach that offers intracellular Mena protein isoforms drugable …
  • National Fuel Gas Co Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    National Fuel Gas Co Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary National Fuel Gas Co (National Fuel) is a diversified energy company that specializes in the production, gathering, transportation, distribution and marketing of natural gas. It operates as an integ …
  • TransMontaigne Product Services LLC:企業の戦略的SWOT分析
    TransMontaigne Product Services LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Goodrich Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    Goodrich Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary Goodrich Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive in …
  • OUE Ltd:企業の戦略・SWOT・財務情報
    OUE Ltd - Strategy, SWOT and Corporate Finance Report Summary OUE Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Resolute Energy Corp (REN):石油・ガス:M&Aディール及び事業提携情報
    Summary Resolute Energy Corp (Resolute), a subsidiary of Resolute Holdings LLC, is an oil and gas company that acquires and operates large-scale oil and gas properties. The company mangaes complex enterprise and undertakes complex transactions. It offers considerable acquisitions of producing proper …
  • Creekside Springs, LLC:企業の戦略・SWOT・財務情報
    Creekside Springs, LLC - Strategy, SWOT and Corporate Finance Report Summary Creekside Springs, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Kimco Realty Corp (KIM):企業の財務・戦略的SWOT分析
    Kimco Realty Corp (KIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • CryoLife Inc (CRY):医療機器:M&Aディール及び事業提携情報
    Summary CryoLife Inc (CryoLife) is a provider of biosurgical devices and implantable living tissues for cardiac and vascular surgical procedures. The company’s portfolio enlists preserved human cardiac allografts, vascular allografts, surgical adhesives and sealants, heart valves, carbon dioxide dif …
  • PetroChina Company Limited:企業の戦略・SWOT・財務分析
    PetroChina Company Limited - Strategy, SWOT and Corporate Finance Report Summary PetroChina Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Optimum General Inc.:企業の戦略・SWOT・財務情報
    Optimum General Inc. - Strategy, SWOT and Corporate Finance Report Summary Optimum General Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • PPG Industries Inc (PPG):企業の財務・戦略的SWOT分析
    PPG Industries Inc (PPG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆